Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2023 / May / A Helping Hand
Retina Business and Entrepreneurship

A Helping Hand

How AI models are alleviating the pressure of global healthcare systems

By Maria Znamenska 5/10/2023 2 min read

Share

Credit: Collage images sourced from Rawpixel.com and Flickr.com

In an exciting follow up to “AI to Interpret,” published in The Ophthalmologist back in 2020, the first artificial intelligence (AI) platform for OCT scan analysis has now launched online for public access with FDA clearance currently in process (1). The new Altris AI platform will help alleviate the compounded pressures of the fight against preventable blindness – affecting more than one billion people worldwide – and the global shortage of optometrists (2,3).

Able to detect more than 100 retina pathologies and pathological signs – both widespread and rare – and differentiate between pathological and non-pathological OCT scans within minutes, the new platform provides a promising decision making support tool to help ophthalmologists in their daily practice. Eye care specialists from 140 countries have already registered onto the platform and tested its benefits in clinical practice.

How was the AI model created? First, the Altris AI medical team collected and labeled thousands of OCT scans under my supervision. Our team of ten experts then marked pathologies and pathological signs on all OCT scans inside a special program, preparing them for the model. This activity was followed by the implementation and training of the AI model. Popular neural network architectures for medical imaging, such as UNet and FPn, were used as a starting point alongside necessary proprietary changes that ensured the model was both adaptable yet capable of handling the complex data involved.

This AI tool – along with many others –  is here to help clinicians, offering a second opinion on OCT scans and automating some of the most repetitive tasks of ophthalmology. More than this, the combined knowledge of eye care specialists and AI models may help to reduce human errors among less experienced eye care specialists.

References

  1. The Ophthalmologist, “AI to Interpret” (2020). Available at: https://bit.ly/3ZV9AHo. 
  2. UN News, “One Billion People Have Preventable Eye Conditions” (2019) Available at: http://bit.ly/3L68rI8. 
  3. World Economic Forum “Here’s How We Can Provide Better Eye Care for the World” (2022). Available at: http://bit.ly/3F5g4L6.

About the Author(s)

Maria Znamenska

Maria Znamenska is Medical Director of Altris AI

More Articles by Maria Znamenska

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: